We are live on ! Find out more

15 hedge funds and large institutions have $539K invested in Imunon in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $286K → $539K (+$253K)

0.07% less ownership

Funds ownership: 0.34%0.27% (-0.07%)

17% less funds holding

Funds holding: 1815 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
4
Closed
6
Calls
Puts
Net Calls
Net Calls Change

IMNN Hedge Fund Activity: Q1 2024 in Review

15 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2024, worth a combined $539K — up 89% from $286K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IMNN and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Focus Partners Wealth, opening a new position worth an estimated $25.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $20.1K sold.

  • 15 institutional investors held Imunon (IMNN) as of Q1 2024, down from 18 in Q4 2023.
  • Funds reported $539K of Imunon stock for Q1 2024, up 89% quarter-over-quarter.
  • 3 funds opened new Imunon positions in Q1 2024 and 6 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q1 2024 was Focus Partners Wealth, an estimated $25.5K added.
  • The largest Imunon seller in Q1 2024 was Citadel Advisors, an estimated $20.1K sold.

Based on aggregated 13F filings for Q1 2024.